Pancreatic Cancer Research

ResearcherZhejiang Chinese Medical UniversityNo recent work listed

Hui‐Ju Wang

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5114037430. Sources: OpenAlex.

Their work

Papers
7 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 4 papers

Papers 7

  1. Correction: Functions and clinical applications of exosomes in Pancreatic cancer. First author DOI 10.1007/s11033-023-08906-3↗
  2. Causal effect between gut microbiota and pancreatic cancer: a two-sample Mendelian randomization study. Co-author DOI 10.1186/s12885-023-11493-y↗
  3. The Functional Role of LncRNA UCA1 in Pancreatic Cancer: a mini-review. Last author DOI 10.7150/jca.79171↗
  4. Protocadherin-1 serves as a prognostic biomarker and promotes pancreatic cancer progression by suppressing CD8+ T cell infiltration through CCL5-CCR5 axis. Co-author PMID 38058826↗
  5. Functions and clinical applications of exosomes in pancreatic cancer. First author DOI 10.1007/s11033-022-07765-8↗
  6. Oncolytic Adenovirus Expressing ST13 Increases Antitumor Effect of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Against Pancreatic Ductal Adenocarci… Co-author DOI 10.1089/hum.2020.024↗
  7. AUTS2 is a potential therapeutic target for pancreatic cancer patients with liver metastases. Co-author DOI 10.1016/j.mehy.2015.04.029↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhichen Jiang · 5 shared papers, 2022–2023 · strength 1.02
  2. Weiwei Jin · 4 shared papers, 2022–2023 · strength 0.80
  3. Yiping Mou · 4 shared papers, 2022–2023 · strength 0.80
  4. Mingyang Liu · 2 shared papers, 2023 · strength 0.36
  5. Cen-Cen Sun · 1 shared paper, 2023 · strength 0.22
  6. Li Li · 1 shared paper, 2023 · strength 0.22
  7. Liang Wang · 1 shared paper, 2023 · strength 0.22
  8. Li Li · 1 shared paper, 2023 · strength 0.19
  9. Shaobo Zhang · 1 shared paper, 2023 · strength 0.17
  10. Xiaohao Zheng · 1 shared paper, 2023 · strength 0.17
  11. Fangxia Wang · 1 shared paper, 2023 · strength 0.17
  12. You-Ni Zhang · 1 shared paper, 2020 · strength 0.13
  13. Shibing Wang · 1 shared paper, 2020 · strength 0.13
  14. Yigang Wang · 1 shared paper, 2020 · strength 0.13
  15. Ying‐Yu Ma · 1 shared paper, 2015 · strength 0.05
  16. Dong‐Sheng Huang · 1 shared paper, 2015 · strength 0.05
  17. Yong Kwon Han · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.